Rapidly Developing Psychosis as Complication of Innocent Over-The-Counter Drug Use
One-hundred years ago, Sir William Osier made reference to the physician who practices “a sort of pop-gun pharmacy hitting now the malady and again the patient, he himself, not knowing which.” Today we must also be concerned about the patient turning that pharmacologic pop-gun against himself by using one of the 100,000 available over-the-counter drugs (American Pharmaceutical Association, “Handbook of Non-Prescription Drugs,” 1973).
KeywordsDepression Dementia Histamine Charcoal Dermatitis
Unable to display preview. Download preview PDF.
- American Pharmaceutical Association, “Handbook of Non-Prescription Drugs”, 1973.Google Scholar
- Ayd, F.K. 1976. Physostigmine Therapy for Acute Brain Syndromes Secondary to Control Anticholinergic Toxicity. Drug Therapy Newsletter, 11: 1–4.Google Scholar
- Hall, R.C.W. et al. 1978. The Central Anticholinergic Syndrome - Etiology, Diagnosis, and Management. In Drug Dependence and Alcoholism, Vol. 1, Arnold Schecter (ed.). New York: Plenum Publishing Corp. 1981.Google Scholar
- Jacobs, K.W. 1974. Asthmador: A Legal Hallucinogen. Int. J. of the Addictions, 9 (4): 503–512.Google Scholar
- Rumbaugh, C. 1977. Small Vessel Cerebral Vascular Changes Following Chronic Amphetamine Intoxication. In E. Ellinwood and M. Kilbey (Eds.), pp. 241–251. New York: Plenum Press.Google Scholar
- Rumbaugh, C.L. et al. 1971. Cerebral Vascular Changes Secondary to Amphetamine Abuse in the Experimental Animal (Preliminary Report). Radiology, 101: 345–351.Google Scholar